GNOM vs. TMQ
GNOM (Global X Genomics & Biotechnology ETF) is Health & Biotech Equities fund tracking the Solactive Genomics Index, while TMQ (Trilogy Metals Inc.) is a stock. Over the past 5 years, GNOM returned -11.06%/yr vs 6.82%/yr for TMQ. At a 0.24 correlation, their price movements are largely independent.
Performance
GNOM vs. TMQ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GNOM achieves a 14.90% return, which is significantly higher than TMQ's -17.40% return.
GNOM
- 1D
- 0.90%
- 1M
- 12.22%
- YTD
- 14.90%
- 6M
- 11.42%
- 1Y
- 61.83%
- 3Y*
- 2.88%
- 5Y*
- -11.06%
- 10Y*
- —
TMQ
- 1D
- -3.78%
- 1M
- -12.53%
- YTD
- -17.40%
- 6M
- -26.45%
- 1Y
- 154.29%
- 3Y*
- 87.51%
- 5Y*
- 6.82%
- 10Y*
- 21.94%
GNOM vs. TMQ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
GNOM Global X Genomics & Biotechnology ETF | 14.90% | 18.65% | -15.99% | -8.63% | -36.27% | -15.93% | 51.52% | 2.03% |
TMQ Trilogy Metals Inc. | -17.40% | 271.55% | 169.77% | -21.82% | -66.67% | -17.50% | -23.08% | 3.59% |
Correlation
The correlation between GNOM and TMQ is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.26 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since Apr 10, 2019 | 0.24 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GNOM vs. TMQ — Risk / Return Rank
GNOM
TMQ
GNOM vs. TMQ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Global X Genomics & Biotechnology ETF (GNOM) and Trilogy Metals Inc. (TMQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GNOM | TMQ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.62 | ||
| Sortino ratioReturn per unit of downside risk | -0.74 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 1.47 | -0.11 |
| Calmar ratioReturn relative to maximum drawdown | 3.42 | 2.23 | +1.19 |
| Martin ratioReturn relative to average drawdown | 9.81 | 3.18 | +6.63 |
Loading charts...
Drawdowns
GNOM vs. TMQ - Drawdown Comparison
The maximum GNOM drawdown since its inception was -75.00%, smaller than the maximum TMQ drawdown of -96.55%. Use the drawdown chart below to compare losses from any high point for GNOM and TMQ.
Loading charts...
Drawdown Indicators
| GNOM | TMQ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -75.00% | -96.55% | +21.55% |
Max Drawdown (1Y)Largest decline over 1 year | -18.17% | -69.62% | +51.45% |
Max Drawdown (3Y)Largest decline over 3 years | -44.24% | -69.62% | +25.38% |
Max Drawdown (5Y)Largest decline over 5 years | -72.29% | -85.26% | +12.97% |
Max Drawdown (10Y)Largest decline over 10 years | — | -88.01% | — |
Current DrawdownCurrent decline from peak | -52.52% | -66.42% | +13.90% |
Average DrawdownAverage peak-to-trough decline | -40.63% | -71.91% | +31.28% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.32% | 48.69% | -42.37% |
Volatility
GNOM vs. TMQ - Volatility Comparison
The current volatility for Global X Genomics & Biotechnology ETF (GNOM) is 9.34%, while Trilogy Metals Inc. (TMQ) has a volatility of 23.36%. This indicates that GNOM experiences smaller price fluctuations and is considered to be less risky than TMQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GNOM | TMQ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.34% | 23.36% | -14.02% |
Volatility (6M)Calculated over the trailing 6-month period | 20.57% | 60.10% | -39.53% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.29% | 235.72% | -208.43% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.68% | 128.52% | -94.84% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.17% | 101.17% | -67.00% |
Dividends
GNOM vs. TMQ - Dividend Comparison
GNOM's dividend yield for the trailing twelve months is around 1.20%, while TMQ has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
GNOM Global X Genomics & Biotechnology ETF | 1.20% | 1.37% | 0.00% | 0.00% | 0.00% | 0.03% | 0.14% |
TMQ Trilogy Metals Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
GNOM and TMQ have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TMQ has higher volatility (23.36%) compared to GNOM (9.34%). In terms of maximum drawdown, GNOM dropped -75.00% vs TMQ's -96.55%.
GNOM currently has the higher Sharpe Ratio (2.28 vs 0.66), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GNOM and TMQ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer